Share chart Repligen Corporation
Extended chart
Simple chart
About
Корпорация Repligen разрабатывает и коммерциализирует технологии и системы биообработки для использования в процессе производства биологических препаратов в Северной Америке, Европе, Азиатско-Тихоокеанском регионе и на международном уровне. Он предлагает лиганды протеина А, которые являются связующими компонентами смол для аффинной хроматографии на протеине А; и продукты фактора роста клеточных культур. more detailsIPO date | 1990-03-26 |
---|---|
ISIN | US7599161095 |
Industry | Life Sciences Tools & Services |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | https://www.repligen.com |
Цена ао | 157.7 |
Change price per day: | +1.83% (154.86) |
---|---|
Change price per week: | +2.38% (154.04) |
Change price per month: | +1.1% (155.99) |
Change price per 3 month: | +10.24% (143.05) |
Change price per half year: | +19.19% (132.31) |
Change price per year: | -8.95% (173.21) |
Change price per 3 year: | -12.72% (180.68) |
Change price per 5 year: | +51.3% (104.23) |
Change price per 10 year: | +519.65% (25.45) |
Change price per year to date: | +8.27% (145.65) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
05.12.2024 | 05.12.2024 | Hunt Anthony Director |
Purchase | 33.87 | 399 937 | 11808 | 0 | 0.02 | link |
21.11.2024 | 21.11.2024 | Anthony Hunt Executive Chairman |
Purchase | 139.66 | 3 386 200 | 24246 | 0 | 0.04 | link |
19.11.2024 | 20.11.2024 | MUIR GLENN P Director |
Purchase | 36.29 | 689 510 | 19000 | 0 | 0.03 | link |
02.08.2024 | 05.08.2024 | KURIYEL RALF Senior VP, R&D |
Sale | 159.35 | 1 139 030 | 7148 | 0 | -0.01 | link |
01.08.2024 | 01.08.2024 | Ralf Kuriyel Senior Vice President |
Purchase | 165.67 | 739 717 | 4465 | 0 | 0.01 | link |
01.08.2024 | 01.08.2024 | Christine Gebski Senior Vice President |
Purchase | 167 | 360 720 | 2160 | 0 | 0 | link |
01.08.2024 | 01.08.2024 | KURIYEL RALF Senior VP, R&D |
Sale | 165.67 | 739 717 | 4465 | 0 | -0.01 | link |
23.02.2024 | 26.02.2024 | Bylund James Chief Operating Officer |
Sale | 198.08 | 866 204 | 4373 | 0 | -0.01 | link |
23.02.2024 | 26.02.2024 | Bylund James Chief Operating Officer |
Purchase | 94.33 | 88 670 | 940 | 0 | 0 | link |
29.08.2023 | 30.08.2023 | DAWES KAREN A Director |
Sale | 171.38 | 145 673 | 850 | 0 | 0 | link |
Institutions | Volume | Share, % |
---|---|---|
Blackrock Inc. | 8 | 13.91 |
Vanguard Group Inc | 5 | 9.13 |
Price (T.Rowe) Associates Inc | 4 | 6.39 |
FMR, LLC | 2 | 4.04 |
State Street Corporation | 2 | 3.15 |
Macquarie Group Limited | 1 | 2.62 |
Sands Capital Management, LLC | 1 | 2.56 |
Invesco Ltd. | 1 | 2.22 |
Brown Capital Management, LLC | 1 | 2.07 |
Bank Of New York Mellon Corporation | 1 | 2.03 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Anthony J. Hunt | Executive Chair | 1.59M | 1964 (61 year) |
Mr. James R. Bylund | Chief Operating Officer | 820.26k | 1964 (61 year) |
Mr. Ralf Kuriyel | Senior Vice President of Research & Development | 661.75k | 1958 (67 years) |
Ms. Sondra S. Newman | Global Head of Investor Relations | N/A | |
Mr. Keith Lee Robinson | Chief Information Officer | N/A | |
Ms. Kimberly A. Cornwell | Global Head of Legal | N/A | |
Mr. Olivier Loeillot | President, CEO & Director | N/A | 1970 (55 years) |
Mr. Jason K. Garland | CFO & Chief Compliance Officer | N/A | 1974 (51 year) |
Mr. Neil Whitfield | VP & Global Head of Sales | ||
Ms. Leslie Galvin | Vice President of Human Resources |
Address: United States, Waltham. MA, Building 1 - open in Google maps, open in Yandex maps
Website: https://www.repligen.com
Website: https://www.repligen.com